These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 31915169)

  • 41. The New FDA Real-World Evidence Program to Support Development of Drugs and Biologics.
    Klonoff DC
    J Diabetes Sci Technol; 2020 Mar; 14(2):345-349. PubMed ID: 30862182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making.
    Chen S; Graff J; Yun S; Beal B; Ta JT; Bansal A; Carlson JJ; Veenstra DL; Basu A; Devine B
    J Manag Care Spec Pharm; 2021 Jan; 27(1):95-104. PubMed ID: 33377442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design.
    Xia AD; Schaefer CP; Szende A; Jahn E; Hirst MJ
    Drugs Real World Outcomes; 2019 Dec; 6(4):193-203. PubMed ID: 31741199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trade-offs, fairness, and funding for cancer drugs: key findings from a deliberative public engagement event in British Columbia, Canada.
    Bentley C; Costa S; Burgess MM; Regier D; McTaggart-Cowan H; Peacock SJ
    BMC Health Serv Res; 2018 May; 18(1):339. PubMed ID: 29739463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How do cost-effectiveness analyses inform reimbursement decisions for oncology medicines in Canada? The example of sunitinib for first-line treatment of metastatic renal cell carcinoma.
    Chabot I; Rocchi A
    Value Health; 2010; 13(6):837-45. PubMed ID: 20561332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Developing a model of a patient-group pathway to accessing cancer clinical trials in Canada.
    Batist G; Michaud S; Richards DP; Servidio-Italiano F; Stein BD
    Curr Oncol; 2018 Dec; 25(6):e597-e609. PubMed ID: 30607129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Real world evidence: An Indian perspective.
    Dang A; Vallish BN
    Perspect Clin Res; 2016; 7(4):156-160. PubMed ID: 27843789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A deliberative framework to identify the need for real-life evidence building of new cancer drugs after interim funding decision.
    Leung L; de Lemos ML; Kovacic L
    J Oncol Pharm Pract; 2018 Dec; 24(8):584-598. PubMed ID: 28747103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Value assessment in oncology drugs: funding of drugs for metastatic breast cancer in Canada.
    Lemieux J; Audet S
    Curr Oncol; 2018 Jun; 25(Suppl 1):S161-S170. PubMed ID: 29910659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative's Partnering With Regulators Learning Collaborative.
    Warner JJ; Crook HL; Whelan KM; Bleser WK; Roiland RA; Hamilton Lopez M; Saunders RS; Wang TY; Hernandez AF; McClellan MB; Califf RM; Brown N;
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006606. PubMed ID: 32683985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic review of guidance for the collection and use of patient-reported outcomes in real-world evidence generation to support regulation, reimbursement and health policy.
    Maruszczyk K; Aiyegbusi OL; Torlinska B; Collis P; Keeley T; Calvert MJ
    J Patient Rep Outcomes; 2022 Jun; 6(1):57. PubMed ID: 35652983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evolving use of real-world evidence in the regulatory process: a focus on immuno-oncology treatment and outcomes.
    O'Donnell JC; Le TK; Dobrin R; Higashi M; Pereira A; Wagner S; Yang A; Hukkelhoven M
    Future Oncol; 2021 Jan; 17(3):333-347. PubMed ID: 33074018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU-actions for stakeholders.
    Facey KM; Rannanheimo P; Batchelor L; Borchardt M; de Cock J
    Int J Technol Assess Health Care; 2020 Sep; ():1-10. PubMed ID: 32878663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
    Wu J; Wang C; Toh S; Pisa FE; Bauer L
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-world evidence for coverage decisions: opportunities and challenges.
    Hampson G; Towse A; Dreitlein WB; Henshall C; Pearson SD
    J Comp Eff Res; 2018 Dec; 7(12):1133-1143. PubMed ID: 30411972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measuring the Effectiveness of Real-World Evidence to Ensure Appropriate Impact.
    Brown JP; Douglas IJ; Hanif S; Thwaites RMA; Bate A
    Value Health; 2021 Sep; 24(9):1241-1244. PubMed ID: 34452702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of real-world evidence for healthcare decision-making in the Middle East: practical considerations and future directions.
    Akhras KS; Alsheikh-Ali AA; Kabbani S
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):245-250. PubMed ID: 30626231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The public funding of expensive cancer therapies: synthesizing the "3Es"--evidence, economics, and ethics.
    Kirby J; Somers E; Simpson C; McPhee J
    Organ Ethic; 2008; 4(2):97-108. PubMed ID: 18839752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meta-analyses using real-world data to generate clinical and epidemiological evidence: a systematic literature review of existing recommendations.
    Briere JB; Bowrin K; Taieb V; Millier A; Toumi M; Coleman C
    Curr Med Res Opin; 2018 Dec; 34(12):2125-2130. PubMed ID: 30217138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.